Australian Pharmacist

The significant rise in Australian asthma deaths is cause for immediate and widespread concern. Here’s what experts say needs to change.

After much media scrutiny, the federal Department of Health and Aged Care has announced a ban on compounded GLP-1RAs.

Pharmacists are well equipped to assist patients who request treatment for pain. This article discusses the role of the pharmacist in the appropriate supply of over-the-counter diclofenac for management of pain.

Australia’s Chief Health Officer has approved an amendment to PBS prescription requirements for telehealth consultations as an emergency measure during the COVID-19 response.

From 1 November 2022, the date of birth of every patient must be included on all prescriptions for Schedule 4 and Schedule 8 medicines.

By providing non-judgemental and appropriate counselling on the use of naloxone, pharmacists can empower those who carry it to confidently intervene in the case of opioid toxicity.